Could someone please take the Mastercard away from this dolt?
Im not sure theres anything to be concerned about. They’re only getting a billion in funding. Thats not enough nearly enough for any sort of substantive output. So, Id be real interested in whats actually going to happen w/ this $.
Bullsh!t. Its another industry takeover. The gov makes the most popular drugs at a reduced cost and then forces those on obamacare to use only gov. Created product.
Buy the government label will replace buy the union label.
And Americans will have no choice at all.
scary thought
This is from the Onion or John Semmons - right?
Innovation and discovery, absent the capitalist free market system, is very, very rare. Government just can’t do it.
Hussein works to destroy the private sector by regulation and then creates a Big Brother competitor funded with tax dollars—ie, limitless capital!!! Ain’t that just charming.
With most of the governments of the world limiting the amount of money drug companies can make and even threatening to steal their patents outright if they don’t produce and sell the drugs cheaply enough, followed by Congress looking to do the same until last November, is there any wonder why drug research has gone downhill?
They already make a pretty good emetic.
Everytime I read the news, I want to puke.
“A gramme is better than a damn.”
oh yeah....all the best scientists will be flocking for a slot on a government payscale....../sarc
aspirin would only take 20 years to get through phase 3 trials.......
THX-1138
read later
the Obama administration is starting a federal drug development center, aiming to spur the creation of new medicines.
. . . and how exactly does he have authority to do this?
Tax their profits, use the tax to go into completion with them. This will stimulate them to, what? Go out of business?
Let’s see how far they get when they have to go up against that other model of government efficiency - the FDA. They want to know why new drugs aren’t developed fast enough? Look no further than the FDA. Especially Dendreon’s prostate cancer immunotherapy, Provenge.